Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio Protocol Launchpad
Zug, Zug, Switzerland
- Ownership
- Private
- Development stage
- Other
01
Overview
Projects incubated and launched via BIO Protocol have progressed from preclinical to early clinical stages, including longevity (VITA-FAST, Phase 2), RNA therapies, rare disease pilots, and brain health supplements. Platform enables funding, fast-tracking, and decentralized development cycles at a fraction of traditional cost/timelines.
- Therapeutic areas
- OtherNeurologyDermatologyMetabolic Disorders
- Modalities
- RNA therapySmall moleculeBiologicmRNA-based drugsPeptides
- Industry
- Drug Discovery Services
02
Partnerships
VitaDAOHairDAOPfizer Ventures (via VitaDAO)University of CopenhagenNewcastle UniversityBinance Labs1kxAnimoca BrandsMaelstrom FundPresto Labs
Beyond the preview
Go deeper on Bio Protocol Launchpad.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio Protocol Launchpad.